Shenzhen Oriental Pharmaceutical Co. Ltd.
FDA inspection history in Shenzhen, China, 2019
- 1
- Form 483
Every document, by year
- Form 483
2019: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2019One Form 483, at Shenzhen, China.
Cited most
Across all Shenzhen Oriental Pharmaceutical Co. observations on file
- 21 CFR 211.192Production record review1
- 21 CFR 211.22Responsibilities of quality control unit1
The complete Shenzhen Oriental Pharmaceutical Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Shenzhen, China
One Form 483 · 2019 · 4 observations
Latest: Form 483, Jan 11, 2019 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2019-01-11 | 483 Form 483 | Shenzhen, China | 4 | $99 |
Investigators on these documents
FEI number 3003677845 · most recent document Jan 11, 2019
About Shenzhen Oriental Pharmaceutical Co. Ltd.
How many FDA Form 483s has Shenzhen Oriental Pharmaceutical Co. Ltd. received?
FDA Intel has 1 Form 483 on file for Shenzhen Oriental Pharmaceutical Co. Ltd.; the most recent is dated Jan 11, 2019.
When was Shenzhen Oriental Pharmaceutical Co. Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Shenzhen Oriental Pharmaceutical Co. Ltd. is a Form 483 dated Jan 11, 2019, for the site in Shenzhen, China.
What did FDA cite at Shenzhen Oriental Pharmaceutical Co. Ltd.?
The regulations cited most in the observations on file for Shenzhen Oriental Pharmaceutical Co. Ltd. are 21 CFR 211.192 (Production record review), 1 time; 21 CFR 211.22 (Responsibilities of quality control unit), 1 time.